CGC Form 4: 45,680 RSUs Awarded to Director with Vesting Schedule
Rhea-AI Filing Summary
Canopy Growth Corp (CGC) reported a grant of 45,680 restricted stock units to director M. Shan Atkins on August 12, 2025. The RSUs were issued as compensation and will vest in three scheduled tranches: 10,578 RSUs on September 29, 2025, 17,551 RSUs on December 31, 2025, and 17,551 RSUs on March 31, 2026. The filing shows the reporting person is a director and the transaction was reported as an acquisition at no cash price. The Form 4 was signed by an attorney-in-fact on August 14, 2025, and provides the standard disclosure of beneficial ownership following the grant.
Positive
- 45,680 RSUs granted to director M. Shan Atkins, disclosed transparently on Form 4
- Defined vesting schedule: 10,578 RSUs vest 09/29/2025, 17,551 vest 12/31/2025, 17,551 vest 03/31/2026
Negative
- None.
Insights
TL;DR: A routine director equity grant with a clear vesting schedule, consistent with compensation alignment practices.
The filing documents a director-level equity award of 45,680 RSUs with defined vesting dates across late 2025 and early 2026, signaling use of time-based equity to align the director's interests with shareholder value over the near term. The Form 4 discloses direct beneficial ownership following the grant and is properly executed by an attorney-in-fact, indicating standard governance and disclosure procedures were followed.
TL;DR: Non-derivative RSU grant reported; transaction appears administrative and not immediately market-moving.
The Form 4 shows an acquisition code transaction of 45,680 common share-equivalent RSUs granted at $0 price, with tranche vesting on 09/29/2025, 12/31/2025, and 03/31/2026. The disclosure is concise and limited to compensation-related ownership change, with no exercise prices or derivative holdings reported. From a reporting standpoint, this is a routine insider compensation disclosure rather than a strategic corporate action.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 45,680 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares reported herein were granted on August 12, 2025, in the form of restricted stock units ("RSUs"). 10,578 of the RSUs will vest on September 29, 2025, 17,551 will vest on December 31, 2025 and 17,551 will vest on March 31, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.